Literature DB >> 23362163

Validation of the automated method VIENA: an accurate, precise, and robust measure of ventricular enlargement.

Hugo Vrenken1, Eline K Vos, W M van der Flier, Ingrid C Sluimer, Keith S Cover, Dirk L Knol, Frederik Barkhof.   

Abstract

BACKGROUND: In many retrospective studies and large clinical trials, high-resolution, good-contrast 3DT1 images are unavailable, hampering detailed analysis of brain atrophy. Ventricular enlargement then provides a sensitive indirect measure of ongoing central brain atrophy. Validated automated methods are required that can reliably measure ventricular enlargement and are robust across magnetic resonance (MR) image types. AIM: To validate the automated method VIENA for measuring the percentage ventricular volume change (PVVC) between two scans.
MATERIALS AND METHODS: Accuracy was assessed using four image types, acquired in 15 elderly patients (five with Alzheimer's disease, five with mild cognitive impairment, and five cognitively normal elderly) and 58 patients with multiple sclerosis (MS), by comparing PVVC values from VIENA to manual outlining. Precision was assessed from data with three imaging time points per MS patient, by measuring the difference between the direct (one-step) and indirect (two-step) measurement of ventricular volume change between the first and last time points. The stringent concordance correlation coefficient (CCC) was used to quantify absolute agreement.
RESULTS: CCC of VIENA with manual measurement was 0.84, indicating good absolute agreement. The median absolute difference between two-step and one-step measurement with VIENA was 1.01%, while CCC was 0.98. Neither initial ventricular volume nor ventricular volume change affected performance of the method. DISCUSSION: VIENA has good accuracy and good precision across four image types. VIENA therefore provides a useful fully automated method for measuring ventricular volume change in large datasets.
CONCLUSION: VIENA is a robust, accurate, and precise method for measuring ventricular volume change.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  3D imaging; Alzheimer disease; atrophy; brain; computer-assisted image analysis; magnetic resonance imaging; multiple sclerosis

Mesh:

Year:  2013        PMID: 23362163      PMCID: PMC6869396          DOI: 10.1002/hbm.22237

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  26 in total

1.  Mild cognitive impairment: clinical characterization and outcome.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Arch Neurol       Date:  1999-03

2.  Accurate, robust, and automated longitudinal and cross-sectional brain change analysis.

Authors:  Stephen M Smith; Yongyue Zhang; Mark Jenkinson; Jacqueline Chen; P M Matthews; Antonio Federico; Nicola De Stefano
Journal:  Neuroimage       Date:  2002-09       Impact factor: 6.556

3.  Estimating the generalized concordance correlation coefficient through variance components.

Authors:  Josep L Carrasco; Lluís Jover
Journal:  Biometrics       Date:  2003-12       Impact factor: 2.571

4.  A comparison of MR based segmentation methods for measuring brain atrophy progression.

Authors:  Jeroen de Bresser; Marileen P Portegies; Alexander Leemans; Geert Jan Biessels; L Jaap Kappelle; Max A Viergever
Journal:  Neuroimage       Date:  2010-10-01       Impact factor: 6.556

5.  Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes.

Authors:  Declan T Chard; Jonathan S Jackson; David H Miller; Claudia A M Wheeler-Kingshott
Journal:  J Magn Reson Imaging       Date:  2010-07       Impact factor: 4.813

6.  Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database.

Authors:  Sean M Nestor; Raul Rupsingh; Michael Borrie; Matthew Smith; Vittorio Accomazzi; Jennie L Wells; Jennifer Fogarty; Robert Bartha
Journal:  Brain       Date:  2008-07-11       Impact factor: 13.501

7.  Brain and ventricular volumetric changes in frontotemporal lobar degeneration over 1 year.

Authors:  D S Knopman; C R Jack; J H Kramer; B F Boeve; R J Caselli; N R Graff-Radford; M F Mendez; B L Miller; N D Mercaldo
Journal:  Neurology       Date:  2009-05-26       Impact factor: 9.910

8.  Segmentation of brain magnetic resonance images for measurement of gray matter atrophy in multiple sclerosis patients.

Authors:  Kunio Nakamura; Elizabeth Fisher
Journal:  Neuroimage       Date:  2008-10-22       Impact factor: 6.556

Review 9.  FSL.

Authors:  Mark Jenkinson; Christian F Beckmann; Timothy E J Behrens; Mark W Woolrich; Stephen M Smith
Journal:  Neuroimage       Date:  2011-09-16       Impact factor: 6.556

10.  Ventricular enlargement in MS: one-year change at various stages of disease.

Authors:  C M Dalton; K A Miszkiel; P W O'Connor; G T Plant; G P A Rice; D H Miller
Journal:  Neurology       Date:  2006-03-14       Impact factor: 9.910

View more
  10 in total

1.  Different patterns of longitudinal brain and spinal cord changes and their associations with disability progression in NMO and MS.

Authors:  Yaou Liu; Yunyun Duan; Jing Huang; Zhuoqiong Ren; Zheng Liu; Huiqing Dong; Florian Weiler; Horst K Hahn; Fu-Dong Shi; Helmut Butzkueven; Frederik Barkhof; Kuncheng Li
Journal:  Eur Radiol       Date:  2017-06-30       Impact factor: 5.315

2.  The precision of textural analysis in (18)F-FDG-PET scans of oesophageal cancer.

Authors:  Georgia Doumou; Musib Siddique; Charalampos Tsoumpas; Vicky Goh; Gary J Cook
Journal:  Eur Radiol       Date:  2015-05-21       Impact factor: 5.315

3.  Atrophied Brain T2 Lesion Volume at MRI Is Associated with Disability Progression and Conversion to Secondary Progressive Multiple Sclerosis.

Authors:  Antonia Valentina Genovese; Jesper Hagemeier; Niels Bergsland; Dejan Jakimovski; Michael G Dwyer; Deepa P Ramasamy; Alexis A Lizarraga; David Hojnacki; Channa Kolb; Bianca Weinstock-Guttman; Robert Zivadinov
Journal:  Radiology       Date:  2019-09-24       Impact factor: 11.105

4.  Reliability of brain volume measurements: a test-retest dataset.

Authors:  Julian Maclaren; Zhaoying Han; Sjoerd B Vos; Nancy Fischbein; Roland Bammer
Journal:  Sci Data       Date:  2014-10-14       Impact factor: 6.444

5.  An Observational Study to Assess Brain MRI Change and Disease Progression in Multiple Sclerosis Clinical Practice-The MS-MRIUS Study.

Authors:  Robert Zivadinov; Nasreen Khan; Jennie Medin; Pia Christoffersen; Jennifer Price; Jonathan R Korn; Ian Bonzani; Michael G Dwyer; Niels Bergsland; Ellen Carl; Diego Silva; Bianca Weinstock-Guttman
Journal:  J Neuroimaging       Date:  2016-12-05       Impact factor: 2.486

6.  Neurological software tool for reliable atrophy measurement (NeuroSTREAM) of the lateral ventricles on clinical-quality T2-FLAIR MRI scans in multiple sclerosis.

Authors:  Michael G Dwyer; Diego Silva; Niels Bergsland; Dana Horakova; Deepa Ramasamy; Jaqueline Durfee; Manuela Vaneckova; Eva Havrdova; Robert Zivadinov
Journal:  Neuroimage Clin       Date:  2017-06-19       Impact factor: 4.881

7.  Establishing pathological cut-offs for lateral ventricular volume expansion rates.

Authors:  Michael G Dwyer; Jesper Hagemeier; Niels Bergsland; Dana Horakova; Jonathan R Korn; Nasreen Khan; Tomas Uher; Jennie Medin; Diego Silva; Manuela Vaneckova; Eva Kubala Havrdova; Robert Zivadinov
Journal:  Neuroimage Clin       Date:  2018-02-07       Impact factor: 4.881

8.  Predicting clinical progression in multiple sclerosis after 6 and 12 years.

Authors:  I Dekker; A J C Eijlers; V Popescu; L J Balk; H Vrenken; M P Wattjes; B M J Uitdehaag; J Killestein; J J G Geurts; F Barkhof; M M Schoonheim
Journal:  Eur J Neurol       Date:  2019-02-02       Impact factor: 6.089

9.  Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease.

Authors:  Elijah Mak; Li Su; Guy B Williams; Michael J Firbank; Rachael A Lawson; Alison J Yarnall; Gordon W Duncan; Brit Mollenhauer; Adrian M Owen; Tien K Khoo; David J Brooks; James B Rowe; Roger A Barker; David J Burn; John T O'Brien
Journal:  Neurobiol Aging       Date:  2017-03-16       Impact factor: 4.673

10.  Normalized Brain Tissue-Level Evaluation of Volumetric Changes of Youth Athletes Participating in Collision Sports.

Authors:  Pratik Kashyap; Trey E Shenk; Diana O Svaldi; Roy J Lycke; Taylor A Lee; Gregory G Tamer; Eric A Nauman; Thomas M Talavage
Journal:  Neurotrauma Rep       Date:  2022-01-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.